1. Forecast of Statin
Market to 2018
A GBI Research analysis of the statin market projects that
the generic market is expected to grow significantly,
which in turn will lead to a drop in revenues.

2. Global Statin Market
The decline in the global statin market is expected to accelerate into 2018.
25
(2.5%)
Series1, 2011, 20.5
20
Revenue ($bn)
(7.2%)
15
Series1, 2018, 12.2
10
5
0
2004 2011 2018
Source: GBI Research

3. U.S. Statin Market
The U.S. statin market peaked in 2006 with revenues of $12.3 billion but
with the loss of patents for Zocor in 2006 and Lipitor in 2011, revenues are
likely to plunge.
14
12
(1%)
10
Revenue ($bn)
(8.4%)
8
6
4
2
0
2004 2011 2018
Source: GBI Research

4. Global Statin Market, 2004-2018
30 The highly competitive market, growing use of generics and
limited new therapies in development likely will dampen
interest in entering the market.
25 CAGR (2004–2011) : -2.5%
CAGR (2011–2018) : -7.2%
20 CAGR = Compound Annual Growth Rate
Revenue ($bn)
15
10
5
0
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Source: GBI Research